News >

Ongoing Trials Hope to Move DLBCL Field Beyond R-CHOP

Jason Harris
Published: Friday, Sep 14, 2018

Thomas E. Witzig, MD

Thomas E. Witzig, MD
Cure rates in diffuse large B-cell lymphoma (DLBCL) remain relatively unchanged, even following therapeutic additions to the armamentarium and an improved understanding of disease biology.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Medical Crossfire®: How Can We Optimize Outcomes in Head and Neck Cancers with Immunotherapeutic Strategies?Oct 31, 20191.5
The Patient and Provider Connection™: Effective Communication to Optimize the Diagnosis and Management of Irritable Bowel Syndrome and Chronic Idiopathic ConstipationOct 31, 20191.0
Publication Bottom Border
Border Publication